Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

If you’re male and over 25, you’ve likely seen a ton of ads for hair loss products. There’s a war raging between the likes of Hims (aka ForHims.com), Roman (aka getroman.com), and Keeps (keeps.com), ...

In this video, I will talk about recent updates regarding Hims & Hers Health (NYSE: HIMS). Watch the short video to learn more, consider subscribing, and click the special offer link below.

Hims & Hers reported a double beat with Q4 revenue at $481M, a 95% YoY improvement, but faced an 18% stock drop after hours. Despite margin contraction due to new weight loss offerings, adjusted ...